ReviewCancer drug resistance (Alhambra, Calif.)2021

Targeting the PI3K/AKT/mTOR pathway in epithelial ovarian cancer, therapeutic treatment options for platinum-resistant ovarian cancer.

Natasha Rinne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.